Literature DB >> 22704264

Cruel disease, cruel medicine: self-treatment of cutaneous leishmaniasis with harmful chemical substances in Suriname.

Sahienshadebie Ramdas1.   

Abstract

Why are potentially harmful, non-biomedical chemical substances, such as battery acid, chlorine, herbicides, and insecticides, used in the treatment of cutaneous leishmaniasis (CL)? What drives people to use these products as medicine? This article is about perceptions of CL, and the quest for a cure, in Suriname, South America. It highlights the associative style of reasoning behind health seeking and discusses the use of harmful chemical substances as medicines. Cutaneous leishmaniasis, a parasitic disease, affects 1 to 1.5 million people globally. It has a spectrum of clinical manifestations, but the most prominent and disfiguring elements are extensive dermatological ulceration and scar formation from lesions. The data upon which this article is based are derived from anthropological research carried out in different parts of Suriname between September 2009 and December 2010. Data was collected through mainly qualitative methods, including interviewing 205 CL patients using structured questionnaires at the Dermatological Service in the capital Paramaribo. Almost all people with CL said they tried self-treatment, varying from the use of ethno-botanical products to non-biomedical chemical solutions. This article presents and interprets the views and practices of CL patients who sought treatment using harsh chemicals. It argues that a confluence of contextual factors - environmental, occupational, infrastructural, geographical, socio-cultural, economic, socio-psychological - leads to the use of harmful chemical substances to treat CL sores. This study is the first in Suriname - and one of the few done globally - focusing on social and cultural aspects related to CL health seeking. It aims to encourage health policy makers and health professionals to carefully initiate, provide, and evaluate CL treatment and prevention programs.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22704264     DOI: 10.1016/j.socscimed.2012.04.038

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  11 in total

1.  Randomized single-blinded non-inferiority trial of 7 mg/kg pentamidine isethionate versus 4 mg/kg pentamidine isethionate for cutaneous leishmaniaisis in Suriname.

Authors:  Ricardo V P F Hu; Masja Straetemans; Alida D Kent; Leslie O A Sabajo; Henry J C de Vries; Rudy F M Lai A Fat
Journal:  PLoS Negl Trop Dis       Date:  2015-03-20

2.  Global aspirations, local realities: the role of social science research in controlling neglected tropical diseases.

Authors:  Kevin Bardosh
Journal:  Infect Dis Poverty       Date:  2014-10-01       Impact factor: 4.520

3.  Leishmaniasis patients' pilgrimage to access health care in rural Bolivia: a qualitative study using human rights to health approach.

Authors:  Daniel Eid; Miguel San Sebastian; Anna-Karin Hurtig; Isabel Goicolea
Journal:  BMC Int Health Hum Rights       Date:  2019-03-05

4.  "Cheaper and better": Societal cost savings and budget impact of changing from systemic to intralesional pentavalent antimonials as the first-line treatment for cutaneous leishmaniasis in Bolivia.

Authors:  Daniel Eid Rodríguez; Miguel San Sebastian; Anni-Maria Pulkki-Brännström
Journal:  PLoS Negl Trop Dis       Date:  2019-11-06

5.  The Cutaneous Leishmaniasis and the Sand Fly: Knowledge and Beliefs of the Population in Central Morocco (El Hajeb).

Authors:  Karima El-Mouhdi; Abdelkader Chahlaoui; Mohammed Fekhaoui
Journal:  Dermatol Res Pract       Date:  2020-11-18

6.  Community Engagement in Cutaneous Leishmaniasis Research in Brazil, Ethiopia, and Sri Lanka: A Decolonial Approach for Global Health.

Authors:  Kay Polidano; Linda Parton; Suneth B Agampodi; Thilini C Agampodi; Binega H Haileselassie; Jayasundara M G Lalani; Clarice Mota; Helen P Price; Steffane Rodrigues; Getachew R Tafere; Leny A B Trad; Zenawi Zerihun; Lisa Dikomitis
Journal:  Front Public Health       Date:  2022-02-15

Review 7.  Cutaneous Leishmaniasis: A 2022 Updated Narrative Review into Diagnosis and Management Developments.

Authors:  Henry J C de Vries; Henk D Schallig
Journal:  Am J Clin Dermatol       Date:  2022-09-14       Impact factor: 6.233

8.  Exploring the cultural effects of gender on perceptions of cutaneous leishmaniasis: a systematic literature review.

Authors:  Brianne Wenning; Helen Price; Hasara Nuwangi; Kelemework Tafere Reda; Ben Walters; Reem Ehsanullah; Greice Viana; Alina Andras; Lisa Dikomitis
Journal:  Glob Health Res Policy       Date:  2022-09-26

9.  Listening to diverse community voices: the tensions of responding to community expectations in developing a male circumcision program for HIV prevention in Papua New Guinea.

Authors:  Anna Tynan; Peter S Hill; Angela Kelly; Martha Kupul; Herick Aeno; Richard Naketrumb; Peter Siba; John Kaldor; Andrew Vallely
Journal:  BMC Public Health       Date:  2013-08-13       Impact factor: 3.295

10.  Body location of "New World" cutaneous leishmaniasis lesions and its impact on the quality of life of patients in Suriname.

Authors:  Ricardo V P F Hu; Sahienshadebie Ramdas; Pythia Nieuwkerk; Ria Reis; Rudy F M Lai A Fat; Henry J C de Vries; Henk D F H Schallig
Journal:  PLoS Negl Trop Dis       Date:  2020-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.